| 1 |
29290529 | Histone deacetylase inhibitor (HDACi) upregulates activin A and activates the Smad signaling pathway in melanomas. | 2018 Apr |
1 |
| 2 |
30091530 | ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid. | 2018 Sep |
1 |
| 3 |
30583560 | Differential Mechanisms of Cell Death Induced by HDAC Inhibitor SAHA and MDM2 Inhibitor RG7388 in MCF-7 Cells. | 2018 Dec 22 |
2 |
| 4 |
27911270 | SAHA and/or MG132 reverse the aggressive phenotypes of glioma cells: An in vitro and vivo study. | 2017 Jan 10 |
1 |
| 5 |
26314218 | Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents. | 2016 Feb |
1 |
| 6 |
26038719 | Vorinostat enhances chemosensitivity to arsenic trioxide in K562 cell line. | 2015 |
1 |
| 7 |
26050346 | Sensitization of suberoylanilide hydroxamic acid (SAHA) on chemoradiation for human cervical cancer cells and its mechanism. | 2015 |
1 |
| 8 |
26101701 | Targeted inhibition of histone deacetylases and hedgehog signaling suppress tumor growth and homologous recombination in aerodigestive cancers. | 2015 |
1 |
| 9 |
26410576 | Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells. | 2015 Sep 26 |
1 |
| 10 |
26713523 | [Statins enhance anti-tumor effect of suberoylanilide hydroxamic acid on human non-small cell lung carcinoma cells]. | 2015 Sep |
3 |
| 11 |
25116350 | Up-regulation of P21 inhibits TRAIL-mediated extrinsic apoptosis, contributing resistance to SAHA in acute myeloid leukemia cells. | 2014 |
8 |
| 12 |
22944197 | Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers. | 2013 Nov |
1 |
| 13 |
23299388 | Sustained inhibition of deacetylases is required for the antitumor activity of the histone deactylase inhibitors panobinostat and vorinostat in models of colorectal cancer. | 2013 Aug |
1 |
| 14 |
23515411 | A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2. | 2013 Apr 1 |
1 |
| 15 |
23903894 | Vorinostat in combination with bortezomib in patients with advanced malignancies directly alters transcription of target genes. | 2013 Sep |
4 |
| 16 |
24236158 | The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells. | 2013 |
1 |
| 17 |
22075951 | Combination therapy of conditionally replicating adenovirus and histone deacetylase inhibitors. | 2012 Feb |
2 |
| 18 |
22484732 | Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells. | 2012 Jul |
6 |
| 19 |
22711276 | Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid. | 2012 Jul 24 |
1 |
| 20 |
21205092 | Loss of RUNX3 expression by histone deacetylation is associated with biliary tract carcinogenesis. | 2011 Apr |
1 |
| 21 |
21889949 | Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide. | 2011 Nov 15 |
1 |
| 22 |
21933400 | Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines. | 2011 Sep 20 |
2 |
| 23 |
20665144 | A combination treatment with SAHA and ad-p63/p73 shows an enhanced anticancer effect in HNSCC. | 2010 Dec |
1 |
| 24 |
19157955 | Antitumor activity of suberoylanilide hydroxamic acid against human oral squamous cell carcinoma cell lines in vitro and in vivo. | 2009 Sep |
1 |
| 25 |
19440035 | Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat: a highly active combination against human mantle cell lymphoma (MCL) cells. | 2009 Jul |
1 |
| 26 |
19553104 | Cell cycle and apoptotic effects of SAHA are regulated by the cellular microenvironment in HCT116 multicellular tumour spheroids. | 2009 Sep |
2 |
| 27 |
18541724 | Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines. | 2008 Aug 15 |
1 |
| 28 |
17200334 | The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancer. | 2007 Jan 1 |
9 |
| 29 |
16343270 | Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma. | 2006 Jan |
1 |
| 30 |
15661398 | Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines. | 2005 Jan |
2 |
| 31 |
15897598 | Novel histone deacetylase inhibitors in the treatment of thyroid cancer. | 2005 May 15 |
1 |
| 32 |
12446442 | Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells. | 2003 Apr 15 |
2 |
| 33 |
12531799 | Molecular sequelae of histone deacetylase inhibition in human malignant B cells. | 2003 May 15 |
1 |
| 34 |
14679005 | Coadministration of the heat shock protein 90 antagonist 17-allylamino- 17-demethoxygeldanamycin with suberoylanilide hydroxamic acid or sodium butyrate synergistically induces apoptosis in human leukemia cells. | 2003 Dec 1 |
2 |